Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Outlook Therapeutics Inc. OTLK

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.


Top institutional share ownership of Outlook Therapeutics Inc

Name Shares Shares % change Value Value % change
BlackRock Inc. 6,955,607 4.1% $7,094 -40.3%
Vanguard Group Inc 5,619,636 -0.3% $5,731 -42.9%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 3,489,864 0.0% $3,560 -42.7%
IWM - iShares Russell 2000 ETF 2,529,206 0.4% $2,580 -42.5%
Geode Capital Management, Llc 2,057,809 10.4% $2,098 -36.8%
State Street Corp 1,889,339 13.3% $1,927 -35.1%
LVW Advisors, LLC 1,733,633 -0.6% $1,768 -43.0%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 1,306,521 1.3% $1,333 -42.0%
Vista Finance, Llc 1,020,370 3.7% $1,041 -40.6%
Northern Trust Corp 974,901 -0.7% $995 -43.1%

Top institutional buyers of Outlook Therapeutics Inc

Name Shares % change Value % change Shares Value
TIEIX - TIAA-CREF Equity Index Fund Institutional Class 328.4% 369.8% 321,694 $499
VRTIX - Vanguard Russell 2000 Index Fund Institutional Shares 19.3% -15.9% 286,853 $330
State Street Corp 13.3% -35.1% 1,889,339 $1,927
Geode Capital Management, Llc 10.4% -36.8% 2,057,809 $2,098
FSMAX - Fidelity Extended Market Index Fund 8.0% -23.8% 537,623 $618
SWSSX - Schwab Small-Cap Index Fund 5.6% -23.1% 268,482 $303
Charles Schwab Investment Management Inc 4.5% -40.1% 330,977 $338
BlackRock Inc. 4.1% -40.3% 6,955,607 $7,094
Vista Finance, Llc 3.7% -40.6% 1,020,370 $1,041
IWO - iShares Russell 2000 Growth ETF 2.0% -41.6% 943,797 $963

Top institutional sellers of Outlook Therapeutics Inc

Name Shares % change Value % change Shares Value
Renaissance Technologies Llc -71.0% -83.4% 211,400 $216
Two Sigma Advisers, Lp -35.3% -63.0% 350,100 $357
Millennium Management Llc -18.7% -53.5% 290,495 $296
Nuveen Asset Management, LLC -12.5% -56.1% 826,914 $843
IWC - iShares Micro-Cap ETF -6.1% -46.2% 245,387 $250
CSML - IQ Chaikin U.S. Small Cap ETF -4.3% -34.3% 187,692 $267
Northern Trust Corp -0.7% -43.1% 974,901 $995
LVW Advisors, LLC -0.6% -43.0% 1,733,633 $1,768
Vanguard Group Inc -0.3% -42.9% 5,619,636 $5,731
Bank of New York Mellon Corp -0.1% -42.7% 331,949 $339

Information provided by Fintel.io